Zhang Chen felt that the system was a foreign object, maybe this thing was specially arranged by someone else with a heart.

He has always felt a little abrupt about the origin of the system.

Why did this system choose him as an ordinary person.

There are more people in this world than he has the ability, and he doesn't have any outstanding characteristics.

Therefore, in Zhang Chen's view, the use of the system still needs to be cautious, and we should try to avoid over-relying on the system in the future.

After figuring out Elder Li's requirements, Zhang Chen got up to say goodbye and returned to the company with Zhang Yue.

After returning to his office, the first thing Zhang Chen did was to turn on the computer, download the email inside, and then carefully read the information sent by Li Lao.

After learning the specific principle of this plant's anti-virus, Zhang Chen tried to simulate it in the system.

It turned out that this simulation only cost 500 credits.

It is estimated that it is because of the broad-spectrum ability of this plant to resist viruses, so it costs 500 points.

Otherwise, some simulations only cost about 100 points, which has never been so high.

Zhang Chen was very decisive and directly spent 500 points to get the optimization results of plant anti-virus this time.

Quite simply, the system simply fuses the protein to be site-altered with other targeted proteins so that it can specifically bind to the viral replicator.

This not only improves the efficiency of cutting viral RNA, but also enhances the stability and specificity of the technique in individual plant lines.

In this way, it perfectly solves the problem that the strength of this new anti-virus ability fluctuates greatly.

Zhang Chen had to sigh again at the strength of the system, and it was estimated that the dependence on him could not be removed for the time being.

If you want to no longer rely on the system, you must study all the materials in each discipline in the system.

After mastering it perfectly, it can be self-digested, so that all the techniques can be applied to reality.

In this way, we have the confidence to get rid of the dependence of the system, perhaps, it is not enough to eat all the system data.

Because this is the information provided to you by the system, to put it bluntly, this is just the information that the system wants you to see.

But Zhang Chen didn't think too much about it, and he will talk about it later.

At this stage, the most important thing for him is to learn the system materials first.

For the next whole day, Zhang Chen spent the whole day studying.

The time quickly came to the next day.

Zhang Chen received a notice from Xu Zeming that the clinical trial application had been approved.

He immediately organized manpower to send the finished medicine to Shaocheng People's Hospital.

After hearing the news, Mona took the initiative to come to Zhang Chen's office.

"Mr. Zhang, is it time to start a clinical trial, I can be the first drug subject as the first person in the comparison group of healthy people."

"In fact, clinical trials of drugs are risky, are you sure you don't think about it anymore and trust my drug so much?"

Mona replied firmly: "Don't think about it, I want to be this subject, I made such a big mistake before, you choose to forgive me directly, in comparison, I should do this little thing." ”

Zhang Chen nodded slightly, and no longer persuaded him.

He admired the girl in front of him a little now, and his forgiveness for Mona at that time was just a matter of convenience, and he didn't expect her to bring him anything in return.

Now Mona seems to be determined to do something to repay him as a benefactor.

But she chose such a dangerous thing again.

At least in the eyes of others, there is definitely a risk in drug clinical trials.

Anyone with common sense knows that there is no certainty in the development of new drugs.

It's just that Charter is very confident in the drugs produced by this system, otherwise he wouldn't have easily agreed to let Mona be the subject.

After everything was ready, in Shaocheng People's Hospital, the first clinical trial of healthy subjects officially began.

There were not a few people from the company's side, that is, Zhang Chen, Zhang Yue, Tian Wenbin and Jiang Lu, waiting for the results in the hospital.

There are no special requirements for the delivery environment of this gene therapy drug for cardiovascular disease.

It can be administered directly in an ordinary setting, and can be given orally or intravenously, and there is no difference in effect between the two.

So, as a sober and healthy person, Mona of course chooses to take it orally.

In full view of everyone, she tilted her head and took the liquid from the vial directly.

Immediately afterwards, a nurse came over to give Mona a a series of examinations.

This check starts from this moment and continues until the end of the clinical trial.

And to make sure the data is accurate, they even have to check Mona every 10 minutes.

This is the first subject, and it must be fully monitored to ensure Mona's physical condition, in case something happens, it is good to rescue it as soon as possible.

The most nervous people present were Tian Wenbin and Jiang Lu.

This drug has been followed up by the two of them from scratch, and they have expected more than anyone else that this drug can successfully stand out from clinical trials.

And Zhang Chen and Zhang Yue have a full grasp of this medicine.

Now the finished drugs produced by the company are completely no different from the drugs exchanged by Zhang Chen in the system.

At that time, in the face of Zhang Guoyuan's danger, the two of them had already witnessed the miracle of this medicine.

The results of the first examination came out quickly.

Director Zhao Yingbo took the inspection report and excitedly explained to everyone.

"The subject's physical indicators are within the normal range, and there is no change compared to when he was not taking the drug."

"This shows that the first step is successful, if you can draw blood and do some antigen and antibody tests, you can find that after the drug reaches the body of healthy subjects, it can cause the corresponding protein growth, and it is this protein that has the effect of treating and preventing cardiovascular diseases."

Zhang Chen nodded slowly, and explained to everyone with a smile: "According to the pharmacokinetic study of this drug, after half an hour, this clinical trial of healthy subjects can be ended.

But we don't have to worry, then we will trouble Director Zhao, by this time tomorrow, we need to monitor Mona's physical condition all the time in case of accidents, and monitoring for one day will definitely be enough. ”

Zhao Yingbo nodded, and said in a firm tone: "Leave this matter to me, and I will update the results of the examination in real time and send it to your mailbox, as for the second subject, it is an elderly patient who has suffered from cardiovascular disease for many years, do you want to visit Mr. Zhang?" ”

"I must have gone to see it, Zhang Yue, you can accompany me for a trip."

Zhang Chen carried the fruit that had been prepared a long time ago, and under the leadership of Zhao Yingbo, he came to another ward.

This is also a single deluxe room.

Since he voluntarily became a subject, Zhang Chen would not treat them badly in these aspects.

The single ward is only the basic configuration, and the supporting nurses, eating and drinking, Zhang Chen has arranged the highest standards.

Moreover, for all the subjects who participated in the clinical trials of the company's new drugs, Zhang Chen planned to give 500,000 yuan to each of them.

They risked their lives to try this medicine for you, which is a great trust in you, and Zhang Chen cherishes this hard-won sense of trust.